BioSpace News Archive

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results for the fourth quarter and full year 2022, recent business highlights, and upcoming milestones.

SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison ® and Sonazoid ® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform.

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion ® to Coagulate and Contract Soft Tissues.

Frequency Therapeutics, Inc. today announced that interim Chief Executive Officer and Chief Scientific Officer Christopher Loose, Ph.D., will present at the following March healthcare investor conferences.

Viatris Inc. today announced that as it prepares to enter Phase 2 of its previously announced strategic plan in 2024, Scott A. Smith has been appointed by its Board of Directors to lead the execution of that plan as Viatris’ new Chief Executive Officer, effective April 1, 2023.

Evofem Biosciences, Inc. (OTCQB: EVFM ) today announced that two additional U.S. patents which cover Phexxi® (lactic acid, citric acid and potassium bitartrate ) and its labeled indication are now listed in the U.S. Food and Drug Administration (FDA) publication Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book.

Prime Medicine, Inc. announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present a corporate overview at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023 at 9:50 a.m. ET in Boston, MA.

Gain Therapeutics, Inc. presented new pre-clinical data from its Gaucher disease program in a poster presentation at the 19th Annual WORLDSymposium held February 22–26, 2023, in Orlando, Florida.

Immuneering Corporation announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2022 on Monday, March 6 after the close of trading.

Ardelyx, Inc. today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a GI/Microbiome panel discussion at the Cowen 43rd Annual Health Care Conference on Monday March 6, 2023 at 9:10 A.M. Eastern Time in Boston, MA.